Asthma
The rise of digital technologies in respiratory care
In the wake of the COVID-19 pandemic, the way healthcare is managed is moving further into the digital space. Digital technologies are being increasingly investigated and implemented to provide remote and personalised services that optimise healthcare and improve patient outcomes.1–6 For chronic respiratory diseases that require ongoing management, digital monitoring capabilities that record medication usage and web-based / mobile health apps that provide self-management tools and disease information are particularly relevant.1–5,8 Together with the increased availability of remote services that improve healthcare access, these advances have the potential to tackle some of the prevailing issues in disease control in chronic respiratory care.1–5,7,8
See below for a visual summary of applications of digital technology in respiratory care.

Information in this article may discuss drug classes where Teva have a product and products that are not authorised in all countries. Please consult local prescribing information.
Approval code: RESP-TPE-NP-00474 Date of preparation: August 2023
References
- Chan AHY, et al. Pulm Ther 2021;7:345–76
- Bosnic-Anticevich S, et al. Patient Prefer Adherence 2023;17:259–272
- Eikholt AA, et al. Curr Treat Options Allergy 2023;10:28–52
- Bodni R, et al. Eur Respir J 2019;54: PA735
- Pinnock H, et al. Curr Opin Pulm Med 2023;4:302–12
- Whitelaw S, et al. Lancet Digital Health 2020;e435–40
- Pinnock H, et al. ERJ Open Res 2022;8:00111–2022
- Blakey JD, et al. Eur Respir J 2018;52:1801147